Custom panel design
Pick the substances and cut-offs that match your risk, your industry and your insurer's requirements.
Outside DOT authority you set the panel, the cut-offs and the consequences. We build the program to match — and keep it defensible if it is ever challenged.
Once you step outside DOT authority, the federal procedural rules no longer dictate your program. You choose the substances screened, the specimen type, the cut-off levels and what a positive result means for employment. That freedom is useful. It also means your written policy is the only thing standing between you and a wrongful-termination claim.
IPS builds non-DOT programs the same way we build DOT ones: documented, consistent and repeatable. Same collection network, same certified laboratories, same Medical Review Officer — just written to your rules instead of the government's.
Keep the two programs separate. A non-DOT result must never be recorded on a DOT chain-of-custody form, and a DOT test cannot be expanded to cover extra substances. Where an employee sits in both categories, we run two clearly separated programs under one account.
Most employers start with a 5-panel and expand once they see what turns up locally. Common configurations:
| Panel | Typically covers | Best for |
|---|---|---|
| 5-panel | THC, cocaine, opiates, amphetamines, PCP | General workforce screening |
| 10-panel | 5-panel plus barbiturates, benzodiazepines, methadone, propoxyphene, methaqualone | Safety-sensitive and equipment roles |
| 12-panel+ | 10-panel plus expanded opiates, oxycodone, fentanyl and synthetic screens | Healthcare, high-risk and post-incident |
| Alcohol | Breath or EtG | Post-incident and reasonable suspicion |
Construction and skilled trades. Manufacturing and warehousing. Healthcare and staffing agencies. Municipalities. Non-CDL delivery fleets and the office side of trucking companies that already run DOT testing with us. If your insurer, your general contractor or your customer contract requires a testing program, we can build one that satisfies the requirement and produces the certificate to prove it.
Three failures cause almost every non-DOT dispute we see:
We help you close all three. Policy drafting, supervisor guidance and MRO review are part of the service, not add-ons.
Everything that makes a result stand up when an employee, a lawyer or an insurer questions it.
Pick the substances and cut-offs that match your risk, your industry and your insurer's requirements.
A written, distributed, acknowledged policy is your first line of defence. We draft it or audit the one you have.
Point-of-collection screening where speed matters, with laboratory confirmation on every non-negative.
Prescriptions reviewed confidentially by a certified MRO — so you never see medical information you should not have.
Every test logged with reason, date and outcome, so you can show identical treatment across employees.
Run DOT and non-DOT side by side without ever mixing the paperwork.
Non-DOT programs fail when they are ad hoc. We turn yours into a documented, repeatable process.
48h
Program live from kick-off
100%
Non-negatives lab-confirmed
We walk through your roles, risks, insurer requirements and any customer-contract obligations.
Substances, panels, testing reasons, consequences and the appeal path — in plain language your staff can acknowledge.
Employees are added to the program and supervisors are briefed on how to order a test correctly.
Collections at any of 1500+ sites or on site, with laboratory confirmation on non-negatives.
Legitimate prescriptions resolved confidentially before a result ever reaches you.
Every test archived with its reason and outcome, exportable for insurers, contracts and audits.
DOT testing is federally mandated and follows 49 CFR Part 40 exactly — fixed panel, fixed procedures, fixed consequences. Non-DOT testing is governed by your own written policy: you choose the panel, the specimen type, the cut-offs and what happens after a positive. The collection and laboratory process can look similar, but the paperwork must be kept entirely separate.
Yes — in a non-DOT program. You can screen for benzodiazepines, barbiturates, methadone, fentanyl, synthetic cannabinoids and more. What you cannot do is add those substances to a DOT test or record them on a DOT chain-of-custody form.
Practically, yes. Some states and many insurance and contract requirements make it mandatory, and without a distributed, acknowledged policy you have very little defence if a termination is challenged. We draft the policy as part of setting up your program.
A rapid negative is generally fine to accept. A rapid non-negative is only a screen — it must be sent to a laboratory for confirmation and reviewed by an MRO before you take any employment action. Acting on an unconfirmed screen is the single most common non-DOT mistake we see.
Yes, in a non-DOT program. Hair gives roughly a 90-day detection window, which makes it useful for identifying a pattern of use rather than a single recent episode. It is poor at detecting use in the last few days, so many employers pair it with a urine screen.
Still have a question? Call 248-526-9000 or send us a message.
Tell us your industry and headcount — we'll recommend a panel, draft the policy and quote it the same business day.
We reply the same business day. No setup fees, no long-term lock-in.
Your email client should have opened with the details filled in. If it didn't, email us at info@ipsdrugtesting.com.